| Association of low serum concentration of bilirubin with increased risk of coronary artery disease HA Schwertner, WG Jackson, G Tolan Clinical chemistry 40 (1), 18-23, 1994 | 1138 | 1994 |
| Gilbert syndrome, UGT1A1* 28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin HA Schwertner, L Vítek Atherosclerosis 198 (1), 1-11, 2008 | 283 | 2008 |
| The heme catabolic pathway and its protective effects on oxidative stress‐mediated diseases L Vítek, HA Schwertner Advances in clinical chemistry 43, 1-57, 2007 | 261 | 2007 |
| High-performance liquid chromatographic analysis of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol in ginger-containing dietary supplements, spices, teas, and beverages HA Schwertner, DC Rios Journal of Chromatography B 856 (1-2), 41-47, 2007 | 212 | 2007 |
| Association of smoking and low serum bilirubin antioxidant concentrations HA Schwertner Atherosclerosis 136 (2), 383-387, 1998 | 209 | 1998 |
| Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease JP Lin, L Vitek, HA Schwertner Clinical chemistry 56 (10), 1535-1543, 2010 | 195 | 2010 |
| Naloxone-induced inhibition of ethanol dependence in mice K Blum, S Futterman, JE Wallace, HA Schwertner Nature 265 (5589), 49-51, 1977 | 171 | 1977 |
| Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease HA Schwertner, JR Fischer Jr Atherosclerosis 150 (2), 381-387, 2000 | 144 | 2000 |
| Lipid composition of plant mitochondria and of chloroplasts HA Schwertner, JB Biale Journal of lipid research 14 (2), 235-242, 1973 | 117 | 1973 |
| Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer A Jirásková, J Novotný, L Novotný, P Vodic̆ka, B Pardini, A Naccarati, ... International journal of cancer 131 (7), 1549-1555, 2012 | 86 | 2012 |
| Variation in concentration and labeling of ginger root dietary supplements HA Schwertner, DC Rios, JE Pascoe Obstetrics & Gynecology 107 (6), 1337-1343, 2006 | 77 | 2006 |
| Impaired theophylline clearance in patients with cor pulmonale. N Vicuna, JL McNay, TM Ludden, H Schwertner British Journal of Clinical Pharmacology 7 (1), 33-37, 1979 | 77 | 1979 |
| Comparison of lipid fatty acids on a concentration basis vs weight percentage basis in patients with and without coronary artery disease or diabetes HA Schwertner, EL Mosser Clinical chemistry 39 (4), 659-663, 1993 | 76 | 1993 |
| Gas-liquid chromatographic determination of cocaine and benzoylecgonine in urine JE Wallace, HE Hamilton, DE King, DJ Bason, HA Schwertner, SC Harris Analytical Chemistry 48 (1), 34-38, 1976 | 74 | 1976 |
| Improved liquid-chromatographic method for determination of serum cortisol. PM Kabra, LL Tsai, LJ Marton Clinical chemistry 25 (7), 1293-1296, 1979 | 69 | 1979 |
| Caffeine and activation theory: effects on health and behavior BD Smith, U Gupta, BS Gupta crc Press, 2006 | 58 | 2006 |
| Determination of modafinil in plasma and urine by reversed phase high-performance liquid-chromatography HA Schwertner, SB Kong Journal of pharmaceutical and biomedical analysis 37 (3), 475-479, 2005 | 58 | 2005 |
| The association between physical activity, physical fitness, and type 2 diabetes mellitus M Wei, HA Schwertner, SN Blair Comprehensive therapy 26 (3), 176-182, 2000 | 54 | 2000 |
| Relationship between cortisol and cholesterol in men with coronary artery disease and type A behavior. HA Schwertner, RG Troxler, GS Uhl, WG Jackson Arteriosclerosis: An Official Journal of the American Heart Association, Inc …, 1984 | 53 | 1984 |
| Suppression of ethanol withdrawal by dopamine K Blum, JD Eubanks, JE Wallace, HA Schwertner Experientia 32 (4), 493-495, 1976 | 49 | 1976 |
